BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06408168-completion@plaintrial.com
DTSTAMP:20260928T062533Z
DTSTART;VALUE=DATE:20251208
SUMMARY:Phase II Study of REPotrectinib With or Without Fulvestrant in Pati
 ents With Hormone Receptor-positive Human Epidermal Growth Factor 2-negati
 ve Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Th
 erapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLO
 T Trial) — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06408168
URL:https://plaintrial.com/trial/NCT06408168
END:VEVENT
END:VCALENDAR